Balyasny Asset Management LLC Myriad Genetics Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.99 - $23.22 $18.5 Million - $26.8 Million	-1,155,937 Reduced 79.9%	290,808 $4.66 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $2.5 Million - $3.38 Million	-142,232 Reduced 8.95%	1,446,745 $33.5 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $24.2 Million - $37.7 Million	1,588,977 New	1,588,977 $36.9 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $159,428 - $244,089	-8,755 Reduced 25.01%	26,245 $501,000
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $4.71 Million - $7.4 Million	-286,067 Reduced 89.1%	35,000 $636,000
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $7.28 Million - $8.99 Million	321,067 New	321,067 $8.09 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $5.34 Million - $7.22 Million	-221,193 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $6.63 Million - $8.11 Million	221,193 New	221,193 $7.14 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $5.42 Million - $6.96 Million	-213,566 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $6.35 Million - $10.1 Million	-318,529 Reduced 59.86%	213,566 $6.5 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $4.08 Million - $6.63 Million	335,573 Added 170.76%	532,095 $10.5 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $561,836 - $736,629	49,941 Added 34.07%	196,522 $2.56 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $1.57 Million - $2.42 Million	146,581 New	146,581 $1.66 Million
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $878,187 - $1.13 Million	-32,610 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $249,154 - $416,874	-9,150 Reduced 21.91%	32,610 $948,000
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $1.57 Million - $2.1 Million	41,760 New	41,760 $1.92 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $703,601 - $1.02 Million	-25,355 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $113,503 - $161,456	3,937 Added 18.38%	25,355 $749,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $609,342 - $795,464	21,418	21,418 $736,000

Others Institutions Holding MYGN

# of Institutions

248

Shares Held

91.1M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$188 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$128 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$83.4 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$64.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$58.4 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account